Journal of Medical Economics, Volume 21, Issue 5 (2018)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 21, Issue 5 (2018)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Volume 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Neurology

Article
Societal costs of multiple sclerosis in Ireland
Peter Carney, Derek O’Boyle, Aidan Larkin, Christopher McGuigan & Killian O’Rourke
Pages: 425-437
Published online: 07 Feb 2018
AbstractforSocietal costs of multiple sclerosis in Ireland | Full Text | References | PDF (1.5 MB)
  • 1847 Views
  • 15 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Marginal decision-making in the treatment of refractory epilepsy
Jonathan C. Edwards, Russell S. Sobel & Leonardo Bonilha
Pages: 438-442
Published online: 15 Dec 2017
AbstractforMarginal decision-making in the treatment of refractory epilepsy | Full Text | References | PDF (471 KB)
  • 1041 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Addiction Medicine

Article
The association between smoking cessation outpatient visits and total medical costs: a retrospective, observational analysis of Japanese employee-based public health insurance data
Kiyomi Suwa, Reiko Yoshikawa, Kosuke Iwasaki & Ataru Igarashi
Pages: 443-449
Published online: 01 Feb 2018
AbstractforThe association between smoking cessation outpatient visits and total medical costs: a retrospective, observational analysis of Japanese employee-based public health insurance data | Full Text | References | PDF (684.3 KB)
  • 887 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
Healthcare resource utilization among patients with relapsed multiple myeloma in the UK, France, and Italy
Sebastian Gonzalez-McQuire, Kwee Yong, Henri Leleu, Francesco S. Mennini, Alain Flinois, Carlotta Gazzola, Paul Schoen, Marco Campioni, Lucy DeCosta & Leah Fink
Pages: 450-467
Published online: 10 Jan 2018
AbstractforHealthcare resource utilization among patients with relapsed multiple myeloma in the UK, France, and Italy | Full Text | References | PDF (1.5 MB) | Supplemental
  • 2298 Views
  • 14 CrossRef citations
  • 0Altmetric
Free Access

Infectious Disease

Article
A best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment
A. Hendriks, B. Wijnen, R. van Engelen, R. Conde, S.M. Evers, J. Gonzalez, M. Govers, A. Mühlbacher & M. Hiligsmann
Pages: 468-473
Published online: 26 Feb 2018
AbstractforA best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment | Full Text | References | PDF (888.4 KB)
  • 705 Views
  • 10 CrossRef citations
  • 0Altmetric
Free Access

Heor Trends

Article Commentary
Patient value: its nature, measurement, and role in real world evidence studies and outcomes-based reimbursement
Stephen P. McKenna & Jeanette Wilburn
Pages: 474-480
Published online: 23 Mar 2018
AbstractforPatient value: its nature, measurement, and role in real world evidence studies and outcomes-based reimbursement | Full Text | References | PDF (844.6 KB)
  • 3159 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access

Cardiovascular

Article
Use of the THERMOCOOL SMARTTOUCH catheter for ablation of atrial fibrillation: the relationship between hospital procedure volume, re-admissions, and economic outcomes
Andrea Barnow, Laura Goldstein, Iftekhar Kalsekar, Ray Liao & Rahul Khanna
Pages: 481-487
Published online: 17 Jan 2018
AbstractforUse of the THERMOCOOL SMARTTOUCH catheter for ablation of atrial fibrillation: the relationship between hospital procedure volume, re-admissions, and economic outcomes | Full Text | References | PDF (591.5 KB)
  • 828 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Diabetes

Article
The cost-effectiveness of dulaglutide versus insulin glargine for the treatment of type 2 diabetes mellitus in Japan
Hitoshi Ishii, Matthew Madin-Warburton, Alena Strizek, Lucy Thornton-Jones & Shuichi Suzuki
Pages: 488-496
Published online: 07 Feb 2018
AbstractforThe cost-effectiveness of dulaglutide versus insulin glargine for the treatment of type 2 diabetes mellitus in Japan | Full Text | References | PDF (844.9 KB) | Supplemental
  • 2907 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access
Article
Comparison of costs and outcomes of dapagliflozin with other glucose-lowering therapy classes added to metformin using a short-term cost-effectiveness model in the US setting
Abhiroop Chakravarty, Mohini Rastogi, Praveen Dhankhar & Kelly F. Bell
Pages: 497-509
Published online: 01 Mar 2018
AbstractforComparison of costs and outcomes of dapagliflozin with other glucose-lowering therapy classes added to metformin using a short-term cost-effectiveness model in the US setting | Full Text | References | PDF (1.1 MB)
  • 3750 Views
  • 21 CrossRef citations
  • 0Altmetric
Free Access

Health Technology

Article
Relevance of barriers and facilitators in the use of health technology assessment in Colombia
Florian Dams, Javier Leonardo Gonzalez Rodriguez, Kei Long Cheung, Ben F. M. Wijnen & Mickaël Hiligsmann
Pages: 510-517
Published online: 23 Mar 2018
AbstractforRelevance of barriers and facilitators in the use of health technology assessment in Colombia | Full Text | References | PDF (850.9 KB) | Supplemental
  • 1012 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access

Endocrinology

Article
The economic impact of switching from Synthroid for the treatment of hypothyroidism
Nikhil Khandelwal, Beverly Johns, Zsolt Hepp & Jane Castelli-Haley
Pages: 518-524
Published online: 08 Mar 2018
AbstractforThe economic impact of switching from Synthroid for the treatment of hypothyroidism | Full Text | References | PDF (693.2 KB)
  • 3772 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America
Noopur Raje, Garson David Roodman, Wolfgang Willenbacher, Kazuyuki Shimizu, Ramón García-Sanz, Evangelos Terpos, Lisa Kennedy, Lorenzo Sabatelli, Michele Intorcia & Guy Hechmati
Pages: 525-536
Published online: 05 Mar 2018
AbstractforA cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America | Full Text | References | PDF (1.2 MB)
  • 4667 Views
  • 16 CrossRef citations
  • 0Altmetric
Free Access

Dermatology

Report
The budget impact of brodalumab for the treatment of moderate-to-severe plaque psoriasis on US commercial health plans
Steven R. Feldman, Jashin J. Wu, Shipra Rastogi, Brandy Menges, Melissa Lingohr-Smith & Jay Lin
Pages: 537-541
Published online: 02 Feb 2018
AbstractforThe budget impact of brodalumab for the treatment of moderate-to-severe plaque psoriasis on US commercial health plans | Full Text | References | PDF (583.9 KB)
  • 769 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Corrigendum

Article
Correction to: Lane et al., Insulin degludec versus insulin glargine U100 for patients with type 1 or type 2 diabetes in the US: a budget impact analysis with rebate tables.
Ws Lane, James Weatherall, Jens Gundgaard & Richard F. Pollock
Page: 542
Published online: 21 Mar 2018
CitationforCorrection to: Lane et al., Insulin degludec versus insulin glargine U100 for patients with type 1 or type 2 diabetes in the US: a budget impact analysis with rebate tables. | Full Text | PDF (91.5 KB)
  • 245 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles